Evinacumab not checked

Regeneron · REGN1500 · R1500

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2 trial completes
Trials
1 active
7 in total
Targets
 

What this is

How it works
An antibody: a lab-made immune protein built to latch onto one target in the body.-mab: monoclonal antibodies WHO name stem
Tested for
Diabetic Kidney Disease (DKD)
Main trialPhase 2
“This study is researching an experimental drug called ALN-ANG3 (called "study drug"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to see how safe and effective the study drugs are. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times”In the company’s words, NCT07271186 on ClinicalTrials.gov
Other names
REGN1500 · Evkeeza · R1500

Other drugs for Diabetic Kidney Disease (DKD)

All 12 drugs for Diabetic Kidney Disease (DKD)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 13 Oct 2028 Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Phase 3Completed 10 Jun 2019 Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
Phase 3Completed 31 Jan 2022 Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia
Phase 3Completed 13 Apr 2023 Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
Phase 2Completed 17 Dec 2019 Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis
Phase 2Completed 22 May 2020 Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Phase 2Terminated 15 Feb 2023 Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Evinacumab

Following is part of Solo: you see every change to Evinacumab the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in